|
시장보고서
상품코드
2126126
바이오칩 시장(2026-2030년)Global Biochips Market 2026-2030 |
||||||
세계의 바이오칩 시장은 2025년부터 2030년까지 1,008억 3,650만 달러 증가하고, 예측 기간 동안 CAGR은 28.3%에 달할 것으로 예측됩니다.
세계 바이오칩 시장에 관한 본 보고서에서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론, 약 25개 업체를 대상으로 한 벤더 분석을 수록하고 있습니다.
본 보고서는 현재의 시장 상황, 최신 시장 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 주도하는 요인은 다중 바이오마커 분석이 필요한 정밀 종양학으로의 전 세계적 전환 가속화, 현장 진단(Point-of-Care)용 미세유체 기술로의 임상 검사 급속한 분산화, 그리고 ‘장기칩(Organ-on-Chip)’ 플랫폼을 활용한 제약 연구 개발 파이프라인의 확대입니다.
본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 및 2차 정보를 객관적으로 조합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문별 데이터, 그리고 벤더 현황이 수록되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 27.5% |
| CAGR | 28.3% |
| 증가액 | 1,008억 3,650만 달러 |
본 조사에서는 집적 반도체 CMOS 센서를 통한 전자 바이오마커 신호의 직접 검출이 향후 수년간 세계 바이오칩 시장의 성장을 견인할 주요 요인 중 하나라고 규명하고 있습니다. 또한, 미세유체 기술을 활용한 연속 멀티플렉스 모니터링이 가능한 웨어러블 패치형 바이오칩의 상용화와, 칩의 안정성을 높이는 합성 어프타머를 이용한 생체인식 프로브로의 전환에 따라 시장에서 상당한 수요가 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 최종사용자별
제9장 시장 세분화 : 기술별
제10장 시장 세분화 : 제품 유형별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSMThe global biochips market is forecasted to grow by USD 100836.5 mn during 2025-2030, accelerating at a CAGR of 28.3% during the forecast period. The report on the global biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerating global shift precision oncology demanding multiplex biomarker analysis, rapid decentralization clinical testing toward point care microfluidics, pharmaceutical research and development pipeline expansion utilizing organ on chip platforms.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 27.5% |
| CAGR | 28.3% |
| Incremental Value | $100836.5 mn |
Technavio's global biochips market is segmented as below:
By End-User
- Biotech and pharma companies
- Hospitals and diagnostics centers
- Academic and research institutes
By Technology
- Microarrays
- Microfluidics
By Product Type
- DNA chip
- Lab-on-a-chip
- Protein chip
- Others
Geography
- North America
- US
- Canada
- Mexico
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Middle East and Africa
- UAE
- South Africa
- Turkey
- South America
- Brazil
- Argentina
- Chile
- Rest of World (ROW)
This study identifies the integration semiconductor cmos sensors direct electronic biomarker signal detection as one of the prime reasons driving the global biochips market growth during the next few years. Also, implementation microfluidic continuous multiplex monitoring wearable patch biochips and shift toward synthetic aptamers biorecognition probes enhancing chip stability will lead to sizable demand in the market.
The report on the global biochips market covers the following areas:
- Global biochips market sizing
- Global biochips market forecast
- Global biochips market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biochips market vendors that include Abbott Laboratories, Agilent Technologies Inc., Aline Inc., Atomica Corp., BD Biosciences, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., F. Hoffmann La Roche Ltd., Illumina Inc., Macrogen Inc., Micronit BV, QIAGEN N.V., Randox Laboratories Ltd., RayBiotech Life Inc., Revvity Inc., Siemens Healthineers AG, Sony Biotechnology Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., Toray Industries Inc.. Also, the global biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Biochips Market 2020 - 2024
- Historic Market Size - Data Table on Global Biochips Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global biochips market
- 6.2 Impact of geopolitical conflicts on global biochips market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Biotech and pharma companies - Market size and forecast 2025-2030
- 8.4 Hospitals and diagnostics centers - Market size and forecast 2025-2030
- 8.5 Academic and research institutes - Market size and forecast 2025-2030
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- 9.2 Comparison by Technology
- 9.3 Microarrays - Market size and forecast 2025-2030
- 9.4 Microfluidics - Market size and forecast 2025-2030
- 9.5 Market opportunity by Technology
- Market opportunity by Technology ($ million)
10 Market Segmentation by Product Type
- 10.1 Market segments
- 10.2 Comparison by Product Type
- 10.3 DNA chip - Market size and forecast 2025-2030
- 10.4 Lab-on-a-chip - Market size and forecast 2025-2030
- 10.5 Protein chip - Market size and forecast 2025-2030
- 10.6 Others - Market size and forecast 2025-2030
- 10.7 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 APAC - Market size and forecast 2025-2030
- 12.4.1 China - Market size and forecast 2025-2030
- 12.4.2 Japan - Market size and forecast 2025-2030
- 12.4.3 India - Market size and forecast 2025-2030
- 12.4.4 South Korea - Market size and forecast 2025-2030
- 12.4.5 Australia - Market size and forecast 2025-2030
- 12.4.6 Indonesia - Market size and forecast 2025-2030
- 12.5 Europe - Market size and forecast 2025-2030
- 12.5.1 Germany - Market size and forecast 2025-2030
- 12.5.2 UK - Market size and forecast 2025-2030
- 12.5.3 France - Market size and forecast 2025-2030
- 12.5.4 Italy - Market size and forecast 2025-2030
- 12.5.5 Spain - Market size and forecast 2025-2030
- 12.5.6 The Netherlands - Market size and forecast 2025-2030
- 12.6 Middle East and Africa - Market size and forecast 2025-2030
- 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.2 UAE - Market size and forecast 2025-2030
- 12.6.3 South Africa - Market size and forecast 2025-2030
- 12.6.4 Israel - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.7 South America - Market size and forecast 2025-2030
- 12.7.1 Brazil - Market size and forecast 2025-2030
- 12.7.2 Argentina - Market size and forecast 2025-2030
- 12.7.3 Chile - Market size and forecast 2025-2030
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Accelerating global shift precision oncology demanding multiplex biomarker analysis
- Rapid decentralization clinical testing toward point care microfluidics
- Pharmaceutical research and development pipeline expansion utilizing organ on chip platforms
- 13.2 Market challenges
- High initial microfabrication cleanroom production costs restricting commercial accessibility
- Biological surface functionalization inconsistencies causing batch reliability impairment
- Complex interoperability gaps legacy diagnostic equipment impeding integration
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration semiconductor cmos sensors direct electronic biomarker signal detection
- Implementation microfluidic continuous multiplex monitoring wearable patch biochips
- Shift toward synthetic aptamers biorecognition probes enhancing chip stability
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Aline Inc.
- Aline Inc. - Overview
- Aline Inc. - Product / Service
- Aline Inc. - Key offerings
- SWOT
- 15.7 BD Biosciences
- BD Biosciences - Overview
- BD Biosciences - Product / Service
- BD Biosciences - Key offerings
- SWOT
- 15.8 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.9 Boao Bio Group Co. Ltd.
- Boao Bio Group Co. Ltd. - Overview
- Boao Bio Group Co. Ltd. - Product / Service
- Boao Bio Group Co. Ltd. - Key offerings
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 Macrogen Inc.
- Macrogen Inc. - Overview
- Macrogen Inc. - Product / Service
- Macrogen Inc. - Key offerings
- SWOT
- 15.12 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.13 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.14 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.15 Sony Biotechnology Inc.
- Sony Biotechnology Inc. - Overview
- Sony Biotechnology Inc. - Product / Service
- Sony Biotechnology Inc. - Key offerings
- SWOT
- 15.16 Takara Holdings Inc.
- Takara Holdings Inc. - Overview
- Takara Holdings Inc. - Business segments
- Takara Holdings Inc. - Key offerings
- Takara Holdings Inc. - Segment focus
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Toray Industries Inc.
- Toray Industries Inc. - Overview
- Toray Industries Inc. - Business segments
- Toray Industries Inc. - Key news
- Toray Industries Inc. - Key offerings
- Toray Industries Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
